His primary areas of investigation include Internal medicine, Endocrinology, Neuroprotection, Neurotoxicity and Cell biology. His Endocrinology research is multidisciplinary, relying on both Stroke and Alzheimer's disease. Takeshi Kihara combines subjects such as Dopaminergic, Protein kinase B and Kinase, MAPK/ERK pathway with his study of Neuroprotection.
Other disciplines of study, such as Glutamate receptor, Estrogen and Mitochondrion, are mixed together with his Neurotoxicity studies. The concepts of his Glutamate receptor study are interwoven with issues in NMDA receptor and Motor neuron. His Cell biology study incorporates themes from Biochemistry and Astrocyte.
His scientific interests lie mostly in Cell biology, Glutamate receptor, Neuroprotection, Internal medicine and Endocrinology. The Cell biology study combines topics in areas such as Biochemistry, Presenilin and Amyloid precursor protein. His work deals with themes such as NMDA receptor and Pharmacology, which intersect with Glutamate receptor.
In his study, Protein kinase A is strongly linked to Dopaminergic, which falls under the umbrella field of Neuroprotection. His study in Internal medicine is interdisciplinary in nature, drawing from both Progenitor cell and Apoptosis. His studies in Endocrinology integrate themes in fields like Receptor and Cognitive decline.
Cell biology, Amyloid precursor protein, Internal medicine, Biochemistry and Endocrinology are his primary areas of study. His Cell biology study integrates concerns from other disciplines, such as Molecular biology and Presenilin. His work carried out in the field of Amyloid precursor protein brings together such families of science as HEK 293 cells, Amyloid beta and Neuroscience.
Takeshi Kihara has researched Biochemistry in several fields, including Amyloid precursor protein secretase, Beta, Neuroprotection and Senile plaques. His research integrates issues of Biophysics, Neurodegeneration and Thioflavin in his study of Neuroprotection. His Endocrinology study combines topics from a wide range of disciplines, such as Receptor and Cognitive decline.
Takeshi Kihara mostly deals with Amyloid precursor protein, Pharmacology, Neuroprotection, Internal medicine and Endocrinology. His work on P3 peptide as part of general Amyloid precursor protein study is frequently linked to Genetically modified mouse, therefore connecting diverse disciplines of science. The study incorporates disciplines such as Excitotoxicity, Glutamate receptor, NMDA receptor and Neurodegeneration in addition to Pharmacology.
His work investigates the relationship between Neurodegeneration and topics such as Nicotine that intersect with problems in Nicotinic agonist. Among his Neuroprotection studies, there is a synthesis of other scientific areas such as Myricetin and Neurotoxicity. His Endocrinology research incorporates themes from Stroke and Receptor, Antagonist, Peroxisome proliferator-activated receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: